share_log

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(9.7%),New Enterprise Associates 15, L.P.(9.7%), etc.

Addex Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(9.7%),New Enterprise Associates 15, L.P.(9.7%)等

美股SEC公告 ·  2022/11/28 15:19
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息